Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • MehmetZeki
    Junior Member
    • Jan 2024
    • 7

    #1

    Whole Genome Sequencing Missing coverage in sequencing with Novaseq X Plus

    Hello, unfortunately, our Whole Genome sequencing results given with 25B 2x151 cycle on Novaseq X Plus have started to show too many low coverage examples lately. We are loading 64 samples to 25B flowcell. And the expected coverage is 30x

    Has anyone experienced similar problems? Where exactly could the problem be? When we perform sequencing with 10B 2x151 cycles (24 samples, 30x coverage per sample), we do not experience as many problems as with 25B. We have almost never encountered these problems with the 2x151 S4 Flowcell on Novaseq6000 devices.
  • moodystocking
    Junior Member
    • May 2025
    • 1

    #2
    Hi, did you ever find a resolution to this? We are also seeing lower than expected yields on the 25B flowcells

    Comment

    • DM Hagan
      Junior Member
      • Nov 2025
      • 1

      #3
      hi! we are too. We have been quite successful with the 10B, but not the 25B. Can I ask what your final loading concentration is for the 25B?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Today, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      68 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...